Cargando…
Consolidation in multiple myeloma – current status and perspectives
Although multiple myeloma (MM) is still considered an incurable disease, the treatment philosophy is changing due to the introduction of novel agents. Standard treatment consists of an induction phase and autologous stem cell transplantation in patients under 65–70 years. Prolonged treatment (consol...
Autores principales: | Olszewska-Szopa, Magdalena, Rzepecki, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248062/ https://www.ncbi.nlm.nih.gov/pubmed/25477752 http://dx.doi.org/10.5114/wo.2014.45983 |
Ejemplares similares
-
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
por: Lonial, S, et al.
Publicado: (2016) -
Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
por: Piekarowicz, Katarzyna, et al.
Publicado: (2019) -
Minimal residual disease in multiple myeloma: current status
por: Ding, Hong, et al.
Publicado: (2021) -
Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
por: Abramson, Hanley N.
Publicado: (2023) -
Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice
por: Lee, Ho Sup, et al.
Publicado: (2016)